Philip Morris International Inc. Presents at Chief Executives For Corporate Purpose (CECP) 2023 CEO Investor Forum
14 Novembro 2023 - 10:45AM
Business Wire
Regulatory News:
Philip Morris International Inc.’s (NYSE: PM) Chief Executive
Officer, Jacek Olczak, presents today at the Chief Executives For
Corporate Purpose (CECP) 2023 CEO Investor Forum in New York.
The presentation will focus on how PMI has embedded
sustainability across the company, as well as its sustainability
strategy, performance, and progress. PMI’s presentation will follow
CECP’s Integrated Long-Term Plan framework to communicate its
sustainable value creation strategy, strong performance, and key
forward-looking metrics. It will highlight progress towards
achieving PMI’s purpose and business transformation, showcasing how
the health impact of its products is being addressed by focusing
its resources on developing, scientifically substantiating, and
responsibly commercializing smoke-free products that are less
harmful than smoking, with the aim of completely replacing
cigarettes as soon as possible. In addition, as this year’s CEO
Investor Forum will be focused on Climate Action, PMI will also
highlight its low-carbon transition plan and overall approach to
managing its environmental impacts.
The presentation and Q&A session are being webcast live,
beginning at approximately 11:00 a.m. ET, at www.pmi.com/2023CECP,
and on the PMI Investor Relations App available at
www.pmi.com/irapp. An archived copy of the webcast, together with
presentation slides, will be available on the same site and the
App. To learn more about PMI’s decarbonization strategy and
progress to date, read its TCFD Report or Integrated Report 2022,
or visit pmi.com/sustainability.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products.
Since 2008, PMI has invested more than USD 10.5 billion to develop,
scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the
goal of completely ending the sale of cigarettes. This includes the
building of world-class scientific assessment capabilities, notably
in the areas of pre-clinical systems toxicology, clinical and
behavioral research, as well as post-market studies. In November
2022, PMI acquired Swedish Match – a leader in oral nicotine
delivery – creating a global smoke-free champion led by the
companies’ IQOS and ZYN brands. The U.S. Food and Drug
Administration has authorized versions of PMI’s IQOS Platform 1
devices and consumables and Swedish Match’s General snus as
Modified Risk Tobacco Products. As of September 30, 2023, PMI's
smoke-free products were available for sale in 82 markets, and PMI
estimates that approximately 19.7 million adults around the world
had already switched to IQOS and stopped smoking. Smoke-free
products accounted for approximately 36.2% of PMI’s total
third-quarter 2023 net revenues. With a strong foundation and
significant expertise in life sciences, PMI announced in February
2021 its ambition to expand into wellness and healthcare areas and,
through its Vectura Fertin Pharma business, aims to enhance life
through the delivery of seamless health experiences. For more
information, please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231113401726/en/
Philip Morris International Investor Relations: Stamford,
CT: +1 (203) 905 2413 Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024